A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safely of idelalisib on eninhination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia Meeting Abstract


Authors: Salles, G. A.; Lamanna, N.; Amin, B. R.; Boccia, R. V.; Gabrali, N. Y.; Zaydan, M. A. A.; Wong, M.; Adewoye, A. H.; Ghia, P.
Abstract Title: A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safely of idelalisib on eninhination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202187
PROVIDER: wos
Notes: Meeting Abstract: TPS7123 -- Source: Wos
MSK Authors
  1. Nicole Lamanna
    57 Lamanna